Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis

Clinical trial NCT01776684 · UNKNOWN

Trial details

NCT number: NCT01776684
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

EGFR Mutation Positive Non-small Cell Lung Cancer

Start date: 2012-06-01
Primary completion: 2014-05-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.